Cargando…
Response to Initial Anti-Vascular Endothelial Growth Factor for Diabetic Macular Edema Is Significantly Correlated with Response to Third Consecutive Monthly Injection
Purpose: To determine whether the response to the initial anti-vascular endothelial growth factor (anti-VEGF) injection to treat diabetic macular edema (DME) is significantly correlated with the response to the third consecutive monthly injection of the same anti-VEGF agent. Methods: Seventy eyes wi...
Autores principales: | Maeda, Satoshi, Sugimoto, Masahiko, Tenma, Yumiho, Tsukitome, Hideyuki, Kato, Kumiko, Chujo, Shinichiro, Matsui, Yoshitsugu, Matsubara, Hisashi, Kondo, Mineo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9655121/ https://www.ncbi.nlm.nih.gov/pubmed/36362644 http://dx.doi.org/10.3390/jcm11216416 |
Ejemplares similares
-
Expression of vascular infarction-related molecules after anti-vascular endothelium growth factor treatment for diabetic macular edema
por: Sugimoto, Masahiko, et al.
Publicado: (2019) -
Comparison of 2-Year Outcomes between Intravitreal Ranibizumab and Intravitreal Aflibercept for Diabetic Macular Edema with “Treat-and-Extend” Regimen—Its Usefulness and Problems
por: Chujo, Shinichiro, et al.
Publicado: (2020) -
Anti-Vascular Endothelial Growth Factor Treatment for Macular Edema in Eyes with Branch Retinal Vein Occlusion with vs Without Glaucoma – Does Glaucoma Affect Visual Outcome in Eyes with BRVO-ME After antiVEGF Injections?
por: Asami, Shin, et al.
Publicado: (2022) -
Suspension of Anti-VEGF Treatment Does Not Affect Expansion of RPE Atrophy in Neovascular Age-Related Macular Degeneration
por: Chujo, Shinichiro, et al.
Publicado: (2023) -
Which Explanatory Variables Contribute to the Classification of Good Visual Acuity over Time in Patients with Branch Retinal Vein Occlusion with Macular Edema Using Machine Learning?
por: Matsui, Yoshitsugu, et al.
Publicado: (2022)